Delivery Order SPE2DB22D1041-SPE2DB25FUBY6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,750.46 to AmerisourceBergen Drug Corp for the supply of Mucinex ER 1,200 mg tablets (14-count packages). This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,129.30 for Mucinex D ER 600-60 mg tablets (18-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's existing DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $2,526.92. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing relationship with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.68 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packages) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,332.32 to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count packages) with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,091.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucinex ER 600 mg, with an ultimate completion date of July 25, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBY6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.23 to AmerisourceBergen Drug Corp for 500 tablets of Mucinex ER 600 mg on September 10, 2025, with completion scheduled for September 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The delivery order represents routine pharmaceutical procurement through AmerisourceBergen's existing prime vendor relationship with DLA, which leverages the company's extensive portfolio of brand-name and generic medications to support military and federal healthcare systems. AmerisourceBergen's DLA contract demonstrates its critical role in the federal medical supply chain, servicing customers including the Defense Health Agency and other government healthcare entities. The award reflects the company's established capability to provide timely pharmaceutical deliveries through a flexible contracting mechanism that enables the DLA to procure diverse medical commodities efficiently across multiple therapeutic domains in support of military readiness and personnel health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/10/25 |